MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Pilot Study of GVAX in Colorectal Cancer Cells

Phase 1

Terminated

Conditions: Colorectal Cancer

Interventions: Biological: GVAX

First Posted Date: 2013-09-30

Last Posted Date: 2023-01-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 1

Registration Number: NCT01952730

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Neuropeptides in Human Reproduction

Phase 1

Completed

Conditions: Hypogonadotropic Hypogonadism

Interventions: Drug: Kisspeptin 112-121
Drug: Naloxone
Drug: GnRH

First Posted Date: 2013-09-30

Last Posted Date: 2024-07-31

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 61

Registration Number: NCT01952782

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Biomarkers to Predict CRT Response in Patients With HF (BIOCRT)

Completed

Conditions: Heart Failure

First Posted Date: 2013-09-24

Last Posted Date: 2022-10-03

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 221

Registration Number: NCT01949246

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Effectiveness of DECIDE in Patient-Provider Communication, Therapeutic Alliance & Care Continuation

Not Applicable

Completed

Conditions: Mental Disorders

Interventions: Behavioral: DECIDE-PA
Behavioral: DECIDE-PC

First Posted Date: 2013-09-20

Last Posted Date: 2019-03-08

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 481

Registration Number: NCT01947283

Locations: 🇺🇸
Cambridge Health Alliance (Windsor Clinic, Macht Building, Central Street, Malden Primary Care Mental Health), Cambridge, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Family Services of Greater Boston, Boston, Massachusetts, United States

and more 5 locations

Educational Intervention to Reduce Outpatient Inappropriate Transthoracic Echocardiograms

Not Applicable

Completed

Conditions: Inappropriate Use of Echocardiography

Interventions: Behavioral: Educational intervention

First Posted Date: 2013-09-17

Last Posted Date: 2013-09-17

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 112

Registration Number: NCT01944202

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Improving Care After Chemotherapy

Not Applicable

Completed

Conditions: Breast Cancer
Non-small Cell Lung Cancer
Colorectal Cancer

Interventions: Other: Nursing Intervention

First Posted Date: 2013-09-17

Last Posted Date: 2020-09-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 120

Registration Number: NCT01944137

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)

Phase 1

Terminated

Conditions: GVHD
Graft-vs-Host Disease

Interventions: Drug: Brentuximab Vedotin

First Posted Date: 2013-09-12

Last Posted Date: 2018-07-26

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 19

Registration Number: NCT01940796

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Children's Use of the Built Environment for Physical Activity

Not Applicable

Completed

Conditions: Obesity
Overweight

Interventions: Behavioral: built environment use counseling

First Posted Date: 2013-09-11

Last Posted Date: 2017-10-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 60

Registration Number: NCT01939405

Locations: 🇺🇸
Massachusetts General Hospital Revere HealthCare Center, Revere, Massachusetts, United States

Improving Management of Breathlessness in Patients With Lung Cancer

Not Applicable

Completed

Conditions: Lung Cancer
Dyspnea
Breathlessness

Interventions: Behavioral: Cognitive Behavioral Intervention for Breathlessness

First Posted Date: 2013-09-09

Last Posted Date: 2015-07-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 32

Registration Number: NCT01937637

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Genetics of QT Response to Moxifloxacin

Phase 4

Terminated

Conditions: Cardiac Arrhythmias

Interventions: Drug: Moxifloxacin 400mg once time

First Posted Date: 2013-09-06

Last Posted Date: 2022-01-12

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 51

Registration Number: NCT01936480

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy